Augustinerinnen Krankenhaeuser gGmbH

At Augustinerinnen Krankenhaeuser gGmbH in Cologne, the clinical trial portfolio in respiratory tract diseases focuses on lung infections, chronic airway disease, and progressive fibrotic lung conditions. The research is aimed at improving symptom control, reducing exacerbations, and evaluating new treatment options for people with complex pulmonary disorders.

• Adult subjects with newly diagnosed nontuberculous mycobacterial lung infection caused by Mycobacterium avium complex
• Bronchiectasis and related airway infection management
• Idiopathic pulmonary fibrosis and other forms of lung scarring

The studies in this area are exploring whether new therapies can better relieve respiratory symptoms, improve airway clearance and culture outcomes, and slow the decline in lung function.

The site also conducts trials in cardiovascular diseases, with a particular focus on acute clot-related events and chronic heart failure linked with obesity. This work is designed to test more effective treatments and improve outcomes for patients at risk of serious heart and circulatory complications.

• Intermediate-high-risk acute pulmonary embolism
• HFpEF or HFmrEF with obesity

Current research is assessing whether new approaches can reduce the risk of cardiovascular death, hospital admission, and urgent care visits, while also improving recovery after acute pulmonary embolism.